Search research articles
Contact Us
Filters
Showing results (91-100 of 139) with videos related to
Page
of 14
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
July 21, 2006
5-Amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing derivative of mesalamine, exerts antinociceptive effects in a model of postinflammatory hypersensitivity
Eleonora Distrutti, Luca Sediari, Andrea Mencarelli, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 28, 2020
The Bile Acid Receptor GPBAR1 Modulates CCL2/CCR2 Signaling at the Liver Sinusoidal/Macrophage Interface and Reverses Acetaminophen-Induced Liver Toxicity
Michele Biagioli, Adriana Carino, Chiara Fiorucci, et al.
European Journal of Pharmacology
|
May 11, 2011
Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatory bowel diseases and arthritis
Andrea Mencarelli, Eleonora Distrutti, Barbara Renga, et al.
Journal of Hepatology
|
December 4, 2003
NCX-1000, a nitric oxide-releasing derivative of ursodeoxycholic acid, ameliorates portal hypertension and lowers norepinephrine-induced intrahepatic resistance in the isolated and perfused rat liver
Stefano Fiorucci, Elisabetta Antonelli, Vincenzo Brancaleone, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 30, 2005
Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channels
Eleonora Distrutti, Luca Sediari, Andrea Mencarelli, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 11, 2018
Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis
Adriana Carino, Silvia Marchianò, Michele Biagioli, et al.
Diabetes
|
July 10, 2013
Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents
Andrea Mencarelli, Barbara Renga, Claudio D'Amore, et al.
Oncotarget
|
July 14, 2016
The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines
Adriana Carino, Luigina Graziosi, Claudio D'Amore, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
May 3, 2015
Cystathionine γ-lyase, a H2S-generating enzyme, is a GPBAR1-regulated gene and contributes to vasodilation caused by secondary bile acids
Barbara Renga, Mariarosaria Bucci, Sabrina Cipriani, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 4, 2021
Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling
Silvia Marchianò, Michele Biagioli, Rosalinda Roselli, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 139) with videos related to
Sort By:
Page
of 14
The Journal of Pharmacology and Experimental Therapeutics
|
July 21, 2006
5-Amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing derivative of mesalamine, exerts antinociceptive effects in a model of postinflammatory hypersensitivity
Eleonora Distrutti, Luca Sediari, Andrea Mencarelli, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 28, 2020
The Bile Acid Receptor GPBAR1 Modulates CCL2/CCR2 Signaling at the Liver Sinusoidal/Macrophage Interface and Reverses Acetaminophen-Induced Liver Toxicity
Michele Biagioli, Adriana Carino, Chiara Fiorucci, et al.
European Journal of Pharmacology
|
May 11, 2011
Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatory bowel diseases and arthritis
Andrea Mencarelli, Eleonora Distrutti, Barbara Renga, et al.
Journal of Hepatology
|
December 4, 2003
NCX-1000, a nitric oxide-releasing derivative of ursodeoxycholic acid, ameliorates portal hypertension and lowers norepinephrine-induced intrahepatic resistance in the isolated and perfused rat liver
Stefano Fiorucci, Elisabetta Antonelli, Vincenzo Brancaleone, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 30, 2005
Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channels
Eleonora Distrutti, Luca Sediari, Andrea Mencarelli, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 11, 2018
Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis
Adriana Carino, Silvia Marchianò, Michele Biagioli, et al.
Diabetes
|
July 10, 2013
Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents
Andrea Mencarelli, Barbara Renga, Claudio D'Amore, et al.
Oncotarget
|
July 14, 2016
The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines
Adriana Carino, Luigina Graziosi, Claudio D'Amore, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
May 3, 2015
Cystathionine γ-lyase, a H2S-generating enzyme, is a GPBAR1-regulated gene and contributes to vasodilation caused by secondary bile acids
Barbara Renga, Mariarosaria Bucci, Sabrina Cipriani, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 4, 2021
Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling
Silvia Marchianò, Michele Biagioli, Rosalinda Roselli, et al.
Page
of 14